| • |
First and only Artificial Heart to receive
FDA, Health Canada and CE Approval |
| • |
Highest bridge-to-transplant rate* 79% of all approved
BTT devices |
| • |
Highest cardiac output of all mechanical circulatory
support devices (up to 9.5L/min) |
| • |
Set a new benchmark for hemodynamic performance for
these critically ill patients |
| • |
Presently indicated for use as a bridge-to-transplant
– a complete circulatory support system for patients with irreversible biventricular
heart failure |
 |
| |
*New England Journal of Medicine, 8/26/04, “Cardiac Replacement with a Total
Artificial Heart as a Bridge to Transplantation" |
| • |
Occupies space of diseased heart |
| • |
Replaces diseased heart |
| • |
Implanted into heart failure patients who have
a BSA of 1.7 m2 or greater |
| • |
Contains 2 ventricles and 4 artificial valves |
| • |
Presently indicated for use as a bridge-to-transplant
– a complete circulatory support system for patients with irreversible biventricular
heart failure |
| • |
Position of ventricles is adjustable in chest |
| • |
No surgical pocket required |
| • |
Stroke volume is 70 ml |
| • |
Weighs 160 grams |
| • |
Diameter of Inflow Medtronic- Hall valve is 27 mm |
| • |
Diameter of Outflow Medtronic-Hall valve is 25 mm |
| • |
Blood flow path is the same as the normal heart |
| • |
Distance blood travels from the inflow to the ventricle
is <2 cm |
| • |
Distance of the blood path from inflow to outflow is
< 20cm. (shortest distance of any mechanical device, decreasing the risk
of thromboembolitic events) |
| • |
Seamless blood diaphragm |
| • |
Four flexible polyurethane diaphragms. (blood, 2 intermediate
and air diaphragms) |
| • |
Cardiac output up to 9.5 L/min |
